Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

April 26, 2015 9:03 PM ET


Company Overview of Five Prime Therapeutics, Inc.

Key Executives for Five Prime Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Lewis T. Williams M.D., Ph.D.41 RelationshipsFounder, Chief Executive Officer, President and Director65
Marc L. Belsky No RelationshipsChief Financial Officer, Principal Accounting Officer and Senior Vice President59
Julie Hambleton M.D. No RelationshipsChief Medical Officer and Senior Vice President56
Aron Marc Knickerbocker 14 RelationshipsChief Business Officer, Senior Vice President and Director45
Francis W. Sarena No RelationshipsSenior Vice President, General Counsel and Secretary43
View More Key Executives

Five Prime Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Brian G. Atwood MBA 202 RelationshipsVersant Ventures, Inc.61
Lewis T. Williams M.D., Ph.D. 41 RelationshipsFive Prime Therapeutics, Inc.65
Aron Marc Knickerbocker 14 RelationshipsFive Prime Therapeutics, Inc.45
Mark D. McDade 43 RelationshipsUCB S.A.59
Franklin M. Berger CFA, BA, MA, MBA 99 RelationshipsFive Prime Therapeutics, Inc.64
View All Board Members

Five Prime Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee CFA, BA, MA, MBAFranklin M. Berger99 Relationships3 Executives
Compensation Committee Mark D. McDade43 Relationships3 Executives
Nominating Committee M.D.Peder K. Jensen40 Relationships4 Executives
Corporate Governance Committee M.D.Peder K. Jensen40 Relationships4 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Not meaningful
Total Short Term Compensation$525.0K
Total Value of Options
Compensation as of Fiscal Year
Five Prime Therapeutics, Inc. CEO Compensation
Industry Average


The Clorox Company Announces Retirement of Daniel Boggan as Directors, Effective May 13, 2015
April 24, 2015 9:00 PM ET
Worldwise Promotes Jeff Leh to Vice President of Sales
April 22, 2015 10:15 AM ET
Oil-Dri Corp. of America Announces Management Changes
April 17, 2015 8:15 PM ET
P&G Announces Executive Changes
April 14, 2015 1:58 PM ET
David Charne Joins Aunt Fannie's Board of Directors
April 14, 2015 1:38 PM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Five Prime Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at